University of Maryland Medical System Statement on Recent Cyber Incident
April 03, 2025The following statement is in response to media questions about allegations against former UMMC employee Matthew Bathula.
News
Welcome to the University of Maryland Medical Center Newsroom. In this section, you can find the latest news releases, media team contact information and additional resources for journalists.
Contact the Media Team
- During Business Hours: Call 410-328-8919 or email media@umm.edu
- After Business Hours: Email media@umm.edu (monitored every day, 24/7). This is the quickest way to reach a member of the media relations staff. Urgent messages will receive immediate attention.
R Adams Cowley Shock Trauma Center Surgeon to Co-Lead Large International Clinical Trial to Determine Most Effective Treatment for Common Hip Fracture in Older Adults
February 07, 2025A new $10.8 million multicenter clinical trial co-led by Gerard Slobogean, MD, MPH, an orthopaedic trauma surgeon at the R Adams Cowley Shock Trauma Center at the University of Maryland Medical Center (UMMC), will determine if hip replacement surgery, also known as hip arthroplasty, produces better outcomes for patients ages 60 and older than simpler “internal fixation” that has been performed for decades.
University of Maryland Greenebaum Comprehensive Cancer Center Offers Novel Next-Generation CAR T-cell Therapy for B-cell Lymphomas in First-in-Human Clinical Trial
November 25, 2024Researchers at the University of Maryland Greenebaum Comprehensive Cancer Center (UMGCCC) are conducting a first-in-human clinical trial of a novel next-generation CAR T-cell therapy to treat patients with recurrent or difficult-to-treat B-cell lymphomas, which are cancers of the lymphatic system.
R Adams Cowley Shock Trauma Center Honors More Than 80 Trauma Professionals, First Responders Who Saved the Lives of Two Critically Injured Patients
October 26, 2024The R Adams Cowley Shock Trauma Center at the University of Maryland Medical Center (UMMC) hosted its 34th annual Shock Trauma Heroes Celebration tonight, honoring more than 80 trauma professionals and first responders who provided lifesaving care to two critically injured patients.
More Than 260 University of Maryland Medical System Physicians Recognized As “Top Doctors” In Baltimore Magazine 2024 Survey
October 14, 2024More Than 120 University of Maryland Medical Center Physicians Recognized As “Top Doctors” In Baltimore Magazine 2024 Survey
October 14, 2024Baltimore magazine's Top Docs for University of Maryland Medical Center for 2024.
University of Maryland Children’s Hospital Named Among the Nation’s Best for Neonatology by U.S. News & World Report
October 08, 2024The University of Maryland Children’s Hospital (UMCH), located inside the University of Maryland Medical Center in Baltimore, has been recognized as a “Best Children’s Hospital for Neonatology” by U.S. News & World Report.
Early Results from Multiple Myeloma Clinical Trial Prove Cancer Drug Combination Provides Longer Response and Potential Benefit in Disease-Free Survival
October 02, 2024Patients with multiple myeloma, a type of cancer in their white blood cells, have a significantly longer disease-free period and likely long-term survival if they are treated with the monoclonal antibody drug daratumumab along with the standard therapy drug lenalidomide compared to the standard therapy alone.
New Advanced Procedure at the University of Maryland Medical Center Results in Lifesaving Liver Transplant
October 01, 2024A liver transplant recipient from Maryland's Eastern Shore says he's glad to be alive after the transplantation team at the University of Maryland Medical Center (UMMC) used an innovative organ retrieval procedure to recover a liver from a deceased organ donor.
Cancer Patients Who Experience Cognitive Decline After Radiation Treatment for Brain Metastases May Regain Full Neurocognitive Function, New Study Suggests
October 01, 2024Nearly 40 percent of cancer patients who experienced memory loss, brain fog and other cognitive difficulties after radiation treatment for brain metastases regained full neurocognitive function within six months, according to a new analysis by radiation oncology researchers at the University of Maryland Greenebaum Comprehensive Cancer Center (UMGCCC).